A push by Japan’s biggest drugmaker to globalise has come under attack by more than 100 former executives and shareholders, casting a cloud over broader efforts by the country’s top companies to internationalise.
In a letter to Takeda Pharmaceutical, 110 former executives and individual investors questioned the company’s appointment of non-Japanese to several senior positions.
Help employers find you! Check out all the jobs and post your resume.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.